CRP and depressive symptom measurement: Similarly, further studies should be implemented for investigating the different MDD phases and the different clinical depression subtypes, in order to identify whether a specific subgroup of MDD patients may benefit from monitoring CRP levels from a clinical and therapeutic point of view.